When assessing the competitive landscape, many groups have a myopic view which may limit their understanding of important threats and opportunities. Whether your strategy is to defend and protect your market share or to grow through acquisition, having the most rigorous information and timely insight is critical to your success.
inThought provides comprehensive life science and pharmaceutical competitive intelligence with the unique market acuity needed to support your firm’s most important business decisions. Viewed through a lens of scientific expertise, business acumen and creative thinking, we deliver superior insights on the competition.
All of our work is custom and proprietary, based on the unique needs of each client. We work with you to create a list of novel key intelligence questions (KIQs) that will aid in data collection and analysis. We synthesize information and provide updates relevant to the KIQs as they become available. We also track the answers to your KIQs so you can see how they have changed over time, including details on events and opinion relevant to our assessment.
Our competitive intelligence monitoring allows you to quickly identify and gauge the latest clinical and commercial developments for your area of interest. inThought can help you track:
Daily continuous surveillance of relevant news, data, and events is crucial to your understanding of the space. But this is only part of the equation. Even more important is putting this information into context. Your dedicated inThought analyst will briefly summarize what happened, but more importantly, add their initial analysis on how it may alter the landscape and impact your portfolio.
inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.
© 2024 inThought Research. All Rights Reserved.
As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.
With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.
Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.
